Company profile
Claritev Corporation
NYSE: CTEV · Healthcare · Medical - Healthcare Information Services
#157 of 1,418 Healthcare companies by revenue47th-percentile growth
EA Score
61CFH 65DQ 57GM 55SS 66
v0.1 · 65/100 weight · provisional
↑ workforce scale, growth stability · ↓ balance-sheet leverage, listing tenure
Methodology →Revenue TTM
$978.8M
Rev growth YoY (TTM)
+5.5%
Net income (FY)
-$284.3M
Employees
3,000
as of 2026-08-11
Market cap
$580.8M
as of 2026-08-11
Financials — latest annual
SEC EDGAR · USD-normalizedConceptUSDNativeFY
Revenue$965.4M$965.4M2025
Net income-$284.3M-$284.3M2025
Operating income$28.8M$28.8M2025
Total assets$4.9B$4.9B2025
Liabilities$5.1B$5.1B2025
Equity-$173.9M-$173.9M2025
Revenue trend
FY2020 – FY2025 · USD
FY20
FY20
FY20
FY21
FY22
FY23
FY24
FY25
Revenue by segment
Filed disclosures · FY2025
By product
Network Solutions100%
By geography
Not disclosed.
The read
What is Claritev Corporation’s revenue?
Claritev Corporation booked $965.4M in FY2025 revenue, growing 3.7% year over year — about the middle of the pack among Healthcare companies we track, at a -29.4% net margin.
Peers · Healthcare
Tandem Diabetes Care, Inc.67BWELL Health Technologies Corp.71BGuardant Health, Inc.65BMadrigal Pharmaceuticals, Inc.64CThe Pennant Group, Inc.73BIonis Pharmaceuticals, Inc.71BNeighbors
New York →Key facts
CEOTravis S. Dalton
SectorHealthcare
IndustryMedical - Healthcare Information Services
HeadquartersNew York City, NY
ExchangeNYSE: CTEV
Employees3,000
IPO date2020-04-03
Financials: SEC EDGAR (XBRL), USD-normalized per IAS 21 · TTM/quarterly + segments: FMP from filed disclosures · Filings: EDGAR submissions. County headcount and EA Score are in progress — see docs/DATA_GAPS.md.